跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 56 条关于
“Aurobindo”
全部
56
临床试验
2
药物
9
机构
3
资讯
42
去年
EU Approves Aurobindo Pharma's Dyrupeg: New Pegfilgrastim Biosimilar for Chemotherapy Patients
去年
Aurobindo Pharma Acquires Lannett for $250M to Expand US ADHD Therapeutics Portfolio
去年
Aurobindo Pharma's US Subsidiary Receives 11 FDA Observations Following Inspection
去年
Aurobindo Pharma's CuraTeQ Biologics Receives EU GMP Certification for Biosimilar Manufacturing
去年
Aurobindo Pharma Secures Multiple FDA Approvals for Generic Drug Portfolio Expansion
8个月前
Aurobindo Pharma Subsidiary Acquires Khandelwal Labs' Non-Oncology Portfolio for ₹325 Crore
去年
Aurobindo Receives FDA Approval for Generic Cephalexin Tablets
去年
Aurobindo Pharma Gains US FDA Approval for Cephalexin Antibiotic Tablets
5个月前
Aurobindo Pharma's TheraNym Biologics Expands MSD Partnership with $175 Million Mammalian Manufacturing Facility
3个月前
FTC Requires Aurobindo to Divest Four Generic Drugs to Protect Competition in $250 Million Lannett Acquisition
第 1 页,共 5 页
上一页
下一页